Rentokil Initial plc

As of June 30, 2026, Rentokil Initial plc carries a market capitalization of 296.85B, placing it among publicly traded companies globally. Its enterprise value stands at 360.01B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Rentokil Initial plc's next confirmed earnings release is scheduled for February 25, 2027.

As of June 30, 2026, Rentokil Initial plc has 2.52B shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Rentokil Initial plc maintains a current ratio of 1.06, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 14, 2026, Rentokil Initial plc's stock has declined approximately 9.50% over the past 52 weeks.

As of June 30, 2026, Rentokil Initial plc holds 43.17B in cash and equivalents against 106.37B in total debt, resulting in a net debt position of 53.71B. Total book value stands at 96.37B, with working capital of 4.32B providing operational flexibility.

Rentokil Initial plc's most recent stock split took place on May 19, 1997 with a 1:2 split ratio.